Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.350
+0.060 (4.65%)
Dec 20, 2024, 4:00 PM EST - Market closed
Evogene Market Cap
Evogene has a market cap or net worth of $8.78 million as of December 20, 2024. Its market cap has decreased by -70.64% in one year.
Market Cap
8.78M
Enterprise Value
6.05M
1-Year Change
-70.64%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $8.78M, a decrease of -68.65%. That is a compound annual growth rate of -6.52%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SeaStar Medical Holding | 9.19M |
| QT Imaging Holdings | 9.17M |
| BioCardia | 9.03M |
| Conduit Pharmaceuticals | 8.95M |
| Purple Biotech | 8.92M |
| COSCIENS Biopharma | 8.55M |
| Aytu BioPharma | 8.49M |
| CERo Therapeutics Holdings | 8.43M |